-
-
-
-
-
-
-
Artelo Biosciences enters glaucoma market via funded study
-
-
-
-
-
-
-
Artelo Biosciences presents clinical data for two drug candidates
-
-
-
-
-
-
-
D. Boral Capital Upgrades Artelo (ARTL) to Buy, 'Reverse Complete'
-
-
-
-
-
-
-
Artelo Biosciences, Inc. (ARTL) Misses Q1 EPS by 59c
-
-
-
-
-
-
412,990 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

